NHS bans routine use of puberty blockers for gender dysphoria amid safety concerns

The policy will not apply to children currently receiving the treatment.

NHS England has banned the “routine” prescription of puberty blockers for children and young people with gender dysphoria, claiming there is insufficient evidence of their safety.

The decision, announced this week, has already been criticised by clinicians in Australia who specialise in transgender care.